Learn More
Invitrogen™ TATDN1 Polyclonal Antibody

Description
Immunogen sequence: MSRFKFIDIG INLTDPMFRG IYRGVQKHQD DLQDVIGRAV EIGVKKFMIT GGNLQDSKDA LHLAQTNGMF FSTVGCHPTR CGEFEKNNPD LYLKELLNLA ENNKGKVVAI GECGLDFDRL QFCPKDTQLK YFEKQFELSE QTKLPMFLHC RNSHAEFLDI MKRNRDRCVG GVVHSFDGTK EAAAALIDLD LYIGFNGCSL KTEANLEVLK SIPSEKLMIE TDAPWCGVKS THAGSKYIRT AFPTKKKWES GHCLKDRNEP CHIIQILEIM SAVRDEDPLE LANTLYNNTI KVFFPGI; Positive Samples: LO2, A-549, A-431; Cellular Location: Nucleus.
Specifications
Specifications
| Antigen | TATDN1 |
| Applications | ELISA, Western Blot |
| Classification | Polyclonal |
| Concentration | 0.11 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with 50% glycerol and 0.01% thimerosal; pH 7.3 |
| Gene | TATDN1 |
| Gene Accession No. | Q6P1N9 |
| Gene Alias | 2310079P03Rik; CDA11; hepatocarcinoma high expression protein; LOC690068; Putative deoxyribonuclease TATDN1; similar to TatD DNase domain containing 1; TatD DNase domain containing 1; Tatdn1 |
| Gene Symbols | TATDN1 |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.